101 related articles for article (PubMed ID: 15498581)
21. Functional properties of Drosophila dopamine D1-receptors are not altered by the size of the N-terminus.
Gotzes F; Baumann A
Biochem Biophys Res Commun; 1996 May; 222(1):121-6. PubMed ID: 8630055
[TBL] [Abstract][Full Text] [Related]
22. Molecular biology of the invertebrate dopamine receptors.
Mustard JA; Beggs KT; Mercer AR
Arch Insect Biochem Physiol; 2005 Jul; 59(3):103-17. PubMed ID: 15986382
[TBL] [Abstract][Full Text] [Related]
23. Structural insight into the specific interaction between murine SHPS-1/SIRP alpha and its ligand CD47.
Nakaishi A; Hirose M; Yoshimura M; Oneyama C; Saito K; Kuki N; Matsuda M; Honma N; Ohnishi H; Matozaki T; Okada M; Nakagawa A
J Mol Biol; 2008 Jan; 375(3):650-60. PubMed ID: 18045614
[TBL] [Abstract][Full Text] [Related]
24. Opposite regulation of cocaine-induced intracellular signaling and gene expression by dopamine D1 and D3 receptors.
Zhang J; Xu M
Ann N Y Acad Sci; 2006 Aug; 1074():1-12. PubMed ID: 17105899
[TBL] [Abstract][Full Text] [Related]
25. Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8).
Halls ML; Bond CP; Sudo S; Kumagai J; Ferraro T; Layfield S; Bathgate RA; Summers RJ
J Pharmacol Exp Ther; 2005 May; 313(2):677-87. PubMed ID: 15649866
[TBL] [Abstract][Full Text] [Related]
26. Investigations on the interactions of scorpion neurotoxins with the predicted structure of D1 dopamine receptor by protein-protein docking method. A bioinformatics approach.
Sudandiradoss C; Priya Doss CG; Rajasekaran R; Ramanathan K; Purohit R; Sethumadhavan R
C R Biol; 2008 Jul; 331(7):489-99. PubMed ID: 18558372
[TBL] [Abstract][Full Text] [Related]
27. The dopaminergic system in hypertension.
Zeng C; Zhang M; Asico LD; Eisner GM; Jose PA
Clin Sci (Lond); 2007 Jun; 112(12):583-97. PubMed ID: 17492945
[TBL] [Abstract][Full Text] [Related]
28. Structural determinants of pharmacological specificity between D(1) and D(2) dopamine receptors.
Lan H; Durand CJ; Teeter MM; Neve KA
Mol Pharmacol; 2006 Jan; 69(1):185-94. PubMed ID: 16236817
[TBL] [Abstract][Full Text] [Related]
29. Dopamine D1 and D5 receptors differentially regulate oxidative stress through paraoxonase 2 in kidney cells.
Yang S; Yang Y; Yu P; Yang J; Jiang X; Villar VA; Sibley DR; Jose PA; Zeng C
Free Radic Res; 2015 Apr; 49(4):397-410. PubMed ID: 25740199
[TBL] [Abstract][Full Text] [Related]
30. Agonist-dependent and -independent dopamine-1-like receptor signalling differentially regulates downstream effectors.
Roosterman D
FEBS J; 2014 Nov; 281(21):4792-804. PubMed ID: 25154512
[TBL] [Abstract][Full Text] [Related]
31. Mimicry of erythropoietin and interleukin-6 signalling by an antibody/cytokine receptor chimera in murine myeloid 32D cells.
Kawahara M; Ueda H; Tsumoto K; Kumagai I; Nagamune T
J Biochem; 2007 Apr; 141(4):563-71. PubMed ID: 17442704
[TBL] [Abstract][Full Text] [Related]
32. Voltage-Dependent Dopamine Potency at D
Ågren R; Sahlholm K
Front Pharmacol; 2020; 11():581151. PubMed ID: 33117177
[TBL] [Abstract][Full Text] [Related]
33. Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or both.
Besser MJ; Ganor Y; Levite M
J Neuroimmunol; 2005 Dec; 169(1-2):161-71. PubMed ID: 16150496
[TBL] [Abstract][Full Text] [Related]
34. Extracellular loop 3 (ECL3) and ECL3-proximal transmembrane domains VI and VII of the mesotocin and vasotocin receptors confer differential ligand selectivity and signaling activity.
Cho HJ; Moon MJ; Kwon HB; Hwang JI; Seong JY
Gen Comp Endocrinol; 2008 Mar; 156(1):71-82. PubMed ID: 18158152
[TBL] [Abstract][Full Text] [Related]
35. D1 dopamine receptor signalling defect in spontaneous hypertension.
Felder RA; Eisner GM; Jose PA
Acta Physiol Scand; 2000 Jan; 168(1):245-50. PubMed ID: 10691808
[TBL] [Abstract][Full Text] [Related]
36. An aplysia dopamine1-like receptor: molecular and functional characterization.
Barbas D; Zappulla JP; Angers S; Bouvier M; Mohamed HA; Byrne JH; Castellucci VF; DesGroseillers L
J Neurochem; 2006 Jan; 96(2):414-27. PubMed ID: 16336222
[TBL] [Abstract][Full Text] [Related]
37. Tetrahydroisoquinolines as dopaminergic ligands: 1-Butyl-7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity in mice.
Berenguer I; El Aouad N; Andujar S; Romero V; Suvire F; Freret T; Bermejo A; Ivorra MD; Enriz RD; Boulouard M; Cabedo N; Cortes D
Bioorg Med Chem; 2009 Jul; 17(14):4968-80. PubMed ID: 19540762
[TBL] [Abstract][Full Text] [Related]
38. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
Rouillon C; Degoulet M; Chevallier K; Abraini JH; David HN
Brain Res; 2008 Mar; 1198():44-54. PubMed ID: 18261716
[TBL] [Abstract][Full Text] [Related]
39. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
Santanavanich C; Ebadi M; Govitrapong P
J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
[TBL] [Abstract][Full Text] [Related]
40. Differential roles of the dopamine 1-class receptors, D1R and D5R, in hippocampal dependent memory.
Sariñana J; Kitamura T; Künzler P; Sultzman L; Tonegawa S
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8245-50. PubMed ID: 24843151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
